Maternal serum screening for trisomy 18 in the first trimester of pregnancy

Prenatal Diagnosis

Volumn 18, Issue 9, 1998, Pages 907-913

  Biagiotti, Roberto ^a,c   Cariati, Ettore ^a   Brizzi, Laura ^a   Cappelli, Gino ^b   D'Agata, Alberino ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c Clinica Ginecologica e Ostetrica   (Italy)

Author keywords

First trimester screening; Free human chorionic gonadotropin; Pregnancy associated plasma protein A (PAPP A); Trisomy 18

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; AMNIOCENTESIS; ARTICLE; CHORION VILLUS SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MATERNAL AGE; MATERNAL BLOOD; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; TRISOMY 18;

CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FALSE POSITIVE REACTIONS; FEMALE; GESTATIONAL AGE; HUMANS; MATERNAL AGE; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TRISOMY;

EID: 0031725687     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0223(199809)18:9<907::AID-PD371>3.0.CO;2-1     Document Type: Article

References (35)

1. Aitken, D.A., Mccaw, G., Crossley, J.A., Berry, E., Connor, J.M., Spencer, K., Macri, J.N. (1993). First-trimester biochemical screening for fetal chromosome abnormalities and neural tube defects, Prenat. Diagn., 13, 681-689.
2. Barkai, G., Goldman, B., Ries, L., Chaki, R., Zer, T., Cuckle, H.S. (1993). Expanding multiple marker screening for Down's syndrome to include Edward's syndrome, Prenat. Diagn., 13, 843-850.
3. Baty, B.J., Blackburn, B.L., Carey, J.C. (1994). Natural history of trisomy 18 and trisomy 13: I. Growth, physical assessment, medical histories, survival, and recurrence risk, Am. J. Med. Genet., 49, 175-188.
4. Bersinger, N.A., Brizot, M.L., Johnson, A., Snijders, R.J.M., Abbott, J., Schneider, H., Nicolaides, K.H. (1994). First trimester maternal serum pregnancy-associated plasma protein A and pregnancy-specific β1-glycoprotein in fetal trisomies, Br. J. Obstet. Gynaecol., 101, 970-974.
5. Brambati, B., Macintosh, M.C.M., Teisner, B., Maguiness, S., Shrimanker, K., Lanzani, A., Bonacchi, I., Tului, L., Chard, T., Grudzinskas, J.G. (1993). Low maternal serum levels of pregnancy associated plasma protein A (PAPP-A) in the first trimester in association with abnormal fetal karyotype, Br. J. Obstet. Gynaecol., 100, 324-326.
6. Brambati, B., Tului, L., Bonacchi, I., Shrimanker, K., Suzuki, Y., Grudzinskas, J.G. (1994). Serum PAPP-A and free β-hCG are first-trimester screening markers for Down syndrome, Prenat. Diagn., 14, 1043-1047.
7. Brizot, M.L., Snijders, R.J.M., Bersinger, N.A., Kuhn, P., Nicolaides, K.H. (1994a). Maternal serum pregnancy-associated plasma protein A and fetal nuchal translucency thickness for the prediction of fetal trisomies in early pregnancy, Obstet. Gynecol., 84, 918-922.
8. Brizot, M.L., Snijders, R.J.M., Butler, J., Bersinger, N.A., Nicolaides, K.H. (1994b). Maternal serum hCG and fetal nuchal translucency thickness for the prediction of fetal trisomies in the first trimester of pregnancy, Br. J. Obstet. Gynaecol., 102, 127-132.
9. Canick, J.A., Palomaki, G.E., Osathanondh, R. (1990). Prenatal screening for trisomy 18 in the second trimester, Prenat. Diagn., 10, 546-548.
10. Cuckle, H.S., Wald, N.J., Thompson, S.G. (1987). Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and maternal serum alpha-fetoprotein level, Br. J. Obstet. Gynaecol., 94, 387-402.
11. Drugan, A., Johnson, M.P., Isada, N.B., Holzgreve, W., Zador, I.E., Dombrowski, M.P., Sokol, R.J., Hallak, M., Evans, M.I. (1992). The smaller than expected first-trimester fetus is at increased risk for chromosome anomalies, Am. J. Obstet. Gynecol., 167, 1525-1528.
12. Hook, E.B. (1981). Rates of chromosome abnormalities at different maternal ages, Obstet. Gynecol., 58, 282-285.
13. Hook, E.B., Cross, P.K., Jackson, L., Pergament, E., Brambati, B. (1988). Maternal age-specific rates of 47, + 21 and other cytogenetic abnormalities diagnosed in the first trimester of pregnancy in chorionic villus biopsy specimens: comparison with rates expected from observations at amniocentesis, Am. J. Hum. Genet., 42, 797-807.
14. ISTAT (1993). Statishche Demografiche 1986-1990, Roma: Istituto Nazionale di Statistico, 17.
15. Jones, K.L. (1997). Smith's Recognizable Patterns of Human Malformation, 5th edn. Philadelphia: W.B. Saunders Company, 14-15.
16. Krantz, D.A., Larsen, J.W., Buchanan, P.D., Macri, J.N. (1996). First-trimester Down syndrome screening: free β-hCG and pregnancy-associated plasma protein A, Am. J. Obstet. Gynecol., 174, 612-616.
17. Kuhn, P., Brizot, M.L., Pandya, P.P., Snijders, R.J.M., Nicolaides, K.H. (1995). Crown-rump length in chromosomally abnormal fetuses at 10 to 13 weeks' gestation, Am. J. Obstet. Gynecol., 172, 32-35.
18. Leporrier, N., Herrou, M., Herlicoviez, M., Leymarie, P. (1996). The usefulness of hCG and unconjugated oestriol in prenatal diagnosis of trisomy 18, Br. J. Obstet. Gynaecol., 103, 335-338.
19. Lynch, L., Berkowitz, R.L. (1989). First trimester growth delay in trisomy 18, Am. J. Perinatol., 6, 237-239.
20. Nicolaides, K.H., Azar, G., Byrne, D., Mansur, C., Marks, K. (1992). Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy, Br. Med J., 304, 867-869.
21. Nicolaides, K.H., Brizot, M.L., Snijders, R.J.M. (1994). Fetal nuchal translucency thickness: ultrasound screening for fetal trisomy in the first trimester of pregnancy, Br. J. Obstet. Gynaecol., 101, 782-786.
22. Macintosh, M.C.M., Brambati, B., Chard, T., Grudzinskas, J.G. (1995). Crown-rump length in aneuploid fetuses: implications for first-trimester biochemical screening for aneuploidies, Prenat. Diagn., 15, 691-694.
23. Ozturk, M., Milunsky, A., Brambati, B., Sachs, E.S., Miller, S.L., Wands, J. (1990). Abnormal maternal serum levels of human chorionic gonadotropin free subunits in trisomy 18, Am. J. Med. Genet., 36, 480-483.
24. Palomaki, G.E., Knight, G.J., Haddow, J.E., Canick, J.A., Saller, D.N., Jr, Panizza, D.S. (1992). Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotrophin, Prenat. Diagn., 12, 925-930.
25. Palomaki, G.E., Haddow, J.E., Knight, G.J., Wald, N.J., Kennard, A., Canick, J.A., Saller, D.N., Jr, Blitzer, M.G., Dickerman, L.H., Fisher, R., Hansmann, D., Hansmann, M., Luthy, D.A., Summers, A.M., Wyatt, P. (1995). Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin, Prenat. Diagn., 15, 713-723.
26. Pandya, P.P., Snijders, R.J.M., Johnson, S.P., Brizot, M.L., Nicolaides, K.H. (1995). Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation, Br. J. Obstet. Gynaecol., 102, 957-962.
27. Schneider, A.S., Mennuti, M.T., Zackai, E.H. (1981). High cesarean section rate in trisomy 18 birth: a potential indication for late prenatal diagnosis, Am. J. Obstet. Gynecol., 140, 367-370.
28. Snijders, R.J.M., Holzgreve, W., Cuckle, H.S., Nicolaides, K.H. (1994). Maternal age-specific risks for trisomies at 9-14 weeks' gestation, Prenat. Diagn., 14, 543-552.
29. Spencer, K., Macri, J.N., Aitken, D.A., Connor, J.M. (1992). Free β-hCG as first trimester marker for fetal trisomy, Lancet, 399, 1480.
30. Spencer, K., Mallard, A.S., Coombes, E.J., Macri, J.N. (1993). Prenatal screening for trisomy 18 with free β human chorionic gonadotrophin as a marker, Br. Med. J., 307, 1455-1458.
31. Staples, A.J., Robertson, E.F., Ranieri, E., Ryall, R.G., Haan, E.A. (1991). A maternal serum screen for trisomy 18: an extension of maternal serum screening for Down syndrome, Am. J. Hum. Genet., 49, 1025-1033.
32. Van Lith, J.M.M., for the Dutch Working Party on Prenatal Diagnosis (1991). First trimester screening for fetal chromosome abnormalities. Preliminary results, Prenat. Diagn., 11, 621-624.
33. Wald, N.J., Cuckle, H.S., Densem, J.W., Nanchahal, K., Royston, P., Chard, T., Haddow, J.E., Knight, G.J., Palomaki, G.E., Canick, J.A. (1988). Maternal serum screening for Down's syndrome in early pregnancy, Br. Med. J., 297, 883-887.
34. Wald, N.J., George, L., Smith, D., Densem, J.W., Petterson, K. (1996). Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy, Br. J. Obstet. Gynaecol., 103, 407-412.
35. Zimmerman, R., Hucha, A., Savoldelli, G., Binkert, F., Achermann, J., Grudzinskas, J.G. (1996). Serum parameters and nuchal translucency in first trimester screening for fetal chromosomal abnormalities, Br. J. Obstet. Gynaecol., 103, 1009-1014.